We observed a significantly higher number of the activation marker HLA-DR and activated CCR5+ CD4+ T cells in cytobrush specimens post-MDZ treatment, and this was specifically observed in the BV-persistent subgroup. This evidence concerns the gene CD4 and bacterial vaginosis.